After alkaloids, we turn to another way plants make themselves difficult to eat: bitterness.
Bitter melon and ginseng contain terpenoids or saponins, while milk thistle is dominated by flavonolignans. All are secondary metabolites plants use for defense 1. In folk wisdom, bitterness has become shorthand for "cooling inflammation," lowering glucose, protecting the liver, or even providing a great restorative tonic. That intuition carries a shadow of hormesis: bitterness is the plant warning us that it contains toxins, while low-dose stress can sometimes trigger adaptation 2.
The problem is that intuition and data are often separated by a wide gap. Here we bring three folk-medicine celebrities before the clinical evidence and inspect their report cards. The scoring remains unchanged: 1–5 points on four dimensions, followed by an overall star rating and a green, yellow, or red tier.
Bitter Melon: "Natural Insulin"? Not Even Close
Bitter melon may be the most famous "glucose-lowering vegetable" on Chinese tables. It contains charantin, polypeptide-p, and other constituents that produce signals consistent with improved glucose metabolism in animal and cell experiments. From there came the nickname "natural insulin."
In humans, however, the record is thoroughly ambiguous. A 2023 systematic review of the available clinical trials reached a plain conclusion: bitter melon may modestly improve some glucose measures, but certainty is low 3,4. Studies are generally small and low-quality, and their results conflict. Even meta-analyses that find reductions in blood glucose or HbA1c report effects that are small, unstable, and nowhere near those of glucose-lowering medication 4,5. The charantin content also varies widely by cultivar, plant part, and preparation, leaving no dependable answer to the question, "How much would work?"
Bitter melon is a good low-calorie vegetable and perfectly reasonable food. Treating it as medicine, or expecting it to replace metformin or insulin, is a dangerous exaggeration 3,5. Concentrated juice or extracts taken alongside insulin or glucose-lowering drugs may increase the risk of hypoglycemia; do not escalate the dose on your own, and monitor blood glucose.
Score · Bitter melon (both the vegetable and extracts are weak interventions)
- Effectiveness 2 · Safety 4 · Evidence 2 · Practicality 3 → ★★ 🟡
Milk Thistle: An Overrated "Liver Protector"?
Milk thistle's principal active mixture, silymarin, is the staple of "liver support" supplements. For people who stay up late, entertain clients, or drink heavily, a bottle can become a form of psychological insurance.
The evidence depends on the endpoint. In nonalcoholic fatty liver disease, silymarin can modestly lower ALT and AST 6, and that change in liver enzymes is the source of its reputation. But lower enzymes are only a surrogate marker; they do not necessarily mean the liver itself has materially recovered 7. Evidence is insufficient for improved liver histology or meaningful clinical outcomes 8. One trial found a signal in selected secondary measures such as fibrosis, but that finding needs confirmation. More importantly, the classic Cochrane review in alcohol-related and viral liver disease found no reduction in mortality or complications 9.
On the positive side, silymarin is generally safe and causes few adverse effects 10. It is not a liver-saving drug—at most, it is a gentle, low-risk adjunct. Real liver protection means drinking less, sleeping enough, and managing weight and blood glucose. A milk-thistle "liver pill" is closer to buying a mostly useless indulgence offset than undoing the damage.
Score · Milk thistle / silymarin (already a supplement by nature)
- Effectiveness 2 · Safety 4 · Evidence 3 · Practicality 3 → ★★ 🟡
Ginseng: A "Great Tonic" That Resists Standardization
For centuries, ginseng has been synonymous with restoration and longevity, promoted for fatigue, alertness, and immunity. Its active constituents are a diverse family of ginsenosides 11, and mechanistic work does show neurological and metabolic activity 12.
Human evidence contains some weakly positive signals for fatigue. A systematic review and a meta-analysis found small improvements in fatigue ratings 13,14. Yet studies are generally small, short, and at high risk of bias. Fatigue and perceived energy are unusually vulnerable to placebo effects, so blinding quality and expectation can easily influence the scores. The true size of any benefit remains uncertain 13,14.
Ginseng's bigger challenge is standardization. It contains dozens of ginsenosides with different activity profiles, and no single marker captures the effect of the whole root. Asian ginseng and American ginseng differ in both their ginsenoside profiles and processing. Consequently, biological activity can vary enormously between products 11,15. You rarely know how much active material is actually in the bottle in your hand 15.
The fairest positioning is modest: ginseng is a traditional, generally tolerable tonic experience, but evidence for a specific treatment or longevity effect is inadequate.
Score · Ginsenosides
- Effectiveness 2 · Safety 3 · Evidence 2 · Practicality 3 → ★★ 🟡
All three hover around the yellow tier. Bitterness and "great tonic" status arrive first; clinical evidence trails behind. Biological activity does not guarantee a net health benefit, much less a safe and controllable dose. Enjoy them as food or traditional wellness products if you like, but do not inflate the claims.
Next up is an unfairly maligned character: nitrate. The same family of molecules can lower blood pressure when delivered by leafy vegetables 16, yet appear in processed meat that the International Agency for Research on Cancer classifies as a Group 1 carcinogen.
References16
[1]Mithöfer A, Boland W. Plant defense against herbivores: chemical aspects. Annu Rev Plant Biol. 2012;63:431-50.
[2]Calabrese EJ, Baldwin LA. Hormesis: the dose-response revolution. Annu Rev Pharmacol Toxicol. 2003;43:175-97.
[3]Ooi CP, Yassin Z, Hamid TA. Momordica charantia for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2012 Aug;2012(8):CD007845.
[4]Yin RV, Lee NC, Hirpara H, Phung OJ. The effect of bitter melon (Momordica charantia) on glycemic control: a systematic review and meta-analysis. Front Nutr. 2023;10:1200801.
[5]Fuangchan A, Sonthisombat P, Seubnukarn T, Chanouan R, Chotchaisuwat P, Sirigulsatien V, Ingkaninan K, Plianbangchang P, Haines ST. Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients. J Ethnopharmacol. 2011 Mar;134(2):422-8.
[6]Kalopitas G, Antza C, Doundoulakis I, Siargkas A, Kouroumalis E, Germanidis G, Samara M, Chourdakis M. Impact of silymarin in individuals with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Nutrition. 2021 Mar;83:111092.
[7]Fleming TR, DeMets DL. Surrogate end points in clinical trials: are we being misled? Ann Intern Med. 1996 Oct;125(7):605-13.
[8]Wah Kheong C, Nik Mustapha NR, Mahadeva S. A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2017 Dec;15(12):1940-1949.e8.
[9]Rambaldi A, Jacobs BP, Iaquinto G, Gluud C. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev. 2007 Oct;2007(4):CD003620.
[10]Fried MW, Navarro VJ, Afdhal N, Belle SH, Wahed AS, Hawke RL, Doo E, Meyers CM, Reddy KR. Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trial. JAMA. 2012 Jul;308(3):274-82.
[11]Christensen LP. Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutr Res. 2009;55:1-99.
[12]Attele AS, Wu JA, Yuan CS. Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol. 1999 Dec;58(11):1685-93.
[13]Arring NM, Millstine D, Marks LA, Nail LM. Ginseng as a treatment for fatigue: a systematic review. J Altern Complement Med. 2018 Jul;24(7):624-33.
[14]Bach HV, Kim J, Myung SK, Cho YA. Efficacy of ginseng supplements on fatigue and physical performance: a meta-analysis. J Korean Med Sci. 2016 Dec;31(12):1879-86.
[15]Harkey MR, Henderson GL, Gershwin ME, Stern JS, Hackman RM. Variability in commercial ginseng products: an analysis of 25 preparations. Am J Clin Nutr. 2001 Jun;73(6):1101-6.
[16]Kapil V, Khambata RS, Robertson A, Caulfield MJ, Ahluwalia A. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension. 2015 Feb;65(2):320-7.
